TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 11 | 6 | 2 | 10 | -9 | -62 | -7 |
| P | %wins | 100 | 100 | 100 | 100 | 0 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/4/21 14:09 | 12/31/20 | LPCN | Lipocine Inc. | DE | Health | Drug | Pharmaceutical Preparations | Higuchi John W. | UT | D | S | -9 | 1.35 | 0 | -7 | -1 | 694 | D | |||||||||||||||
12/17/20 16:07 | 12/16/20 | LPCN | Lipocine Inc. | DE | Health | Drug | Pharmaceutical Preparations | Higuchi John W. | UT | D | M.d | 0 | 0.00 | 0 | 4 | 1 | 700 | D | |||||||||||||||
3/18/20 11:20 | 3/17/20 | LPCN | Lipocine Inc. | DE | Health | Drug | Pharmaceutical Preparations | Higuchi John W. | UT | D | P | 70 | 0.3161 | 0 | 220 | 46 | 696 | D | |||||||||||||||
1/2/18 18:15 | 12/29/17 | LPCN | Lipocine Inc. | DE | Health | Drug | Pharmaceutical Preparations | Higuchi John W. | UT | D | M.d | 0 | 0.00 | 0 | 1 | 0 | 476 | D | |||||||||||||||
10/2/15 14:35 | 9/30/15 | LPCN | Lipocine Inc. | DE | Health | Drug | Pharmaceutical Preparations | Higuchi John W. | UT | D | P | 63 | 12.68 | 6 | 5 | 1 | 693 | D | 113 | 77 | 33 | -21 | -35 | -21 | -14 | 11 | 6 | 2 | 10 | -9 | -62 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |